US Stock MarketDetailed Quotes

Immunovant (IMVT)

Watchlist
  • 24.790
  • +0.180+0.73%
Trading Apr 8 11:11 ET
5.05BMarket Cap-9.28P/E (TTM)

Immunovant (IMVT) Key Financial Indicators

IMVT Earnings per Share (EPS)

According to the latest financial report of Immunovant, the latest earnings per share (TTM) for the company is -0.61. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

IMVT Free Cash Flow (FCF)

Interested in knowing about Immunovant's free cash flow? The latest report shows it as -92.33M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

IMVT Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Immunovant shows that the company's current ratio is 15.74, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

IMVT Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Immunovant, the quick ratio is 15.03, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

IMVT Return on Equity (ROE)

Want to learn more about the financial health of Immunovant? The latest ROE figure is -14.69%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

IMVT Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Immunovant, the total asset return on investment (ROA) is -13.53%.

Currency: USD

Quarterly

Loading...

IMVT Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Immunovant's latest financial report to see how their gross margin is doing - currently at --.

Currency: USD

Quarterly

Loading...

IMVT Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Immunovant, the net profit margin is --, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More